A quiet war fought with silent weapons?
Lower drug prices.
Disclaimer
I personally do not advocate any process or procedure contained in any of my Blogs. Information presented here is not intended to provide legal or lawful advice, nor medical advice, diagnosis, treatment, cure, or prevent any disease. Views expressed are for educational purposes only.
I surround, protect, purify and make harmless the following in-formation.
Advancing Most Favored Nation [MFN] pricing
Nov 06, 2025
Today, President Donald J. Trump announced the latest in a series of the most significant actions ever taken by our Federal government to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk to dramatically reduce the prices Americans pay for some of the world’s most popular drugs.
The agreement represents a historic reduction in prices for Americans on the two drugs with the highest annual expenditures in the United States, both of which help adults struggling with diabetes, heart disease (Ozempic and Wegovy only), obesity, and other conditions.
The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through TrumpRx.
The price of Zepbound and Orforglipron, if approved, will fall from $1,086 per month to an average of $346 when purchased through TrumpRx.
In the event that the FDA later approves the Wegovy pill, or certain similar “GLP-1” drugs in each company’s pipeline intended to be taken orally rather than as a shot, the initial dose of those drugs will be priced at $150 per month through TrumpRx.
The historic reduction in prices negotiated by President Trump will enable Medicare and Medicaid to cover obesity drugs for adults at a dramatically lower cost to taxpayers than that proposed by the Biden Administration.
The Medicare prices of Ozempic, Wegovy, Mounjaro, and Zepbound will be $245, less than half the prices proposed by the Biden Administration on such drugs. State Medicaid programs will also have access to these medications at these prices.
These low prices will enable Medicare to cover Wegovy and Zepbound for patients with obesity and related comorbidities for the first time.
Medicare beneficiaries will pay a co-pay of just $50 per month.
Additionally, the agreement provides for reduced costs on other Eli Lilly and Novo Nordisk medicines when purchased through TrumpRx. For example:
Eli Lilly will provide Emgality, a treatment for migraines, at $299 per pen, a discount of $443 off of the list price.
Eli Lilly will provide Trulicity, a commonly used diabetes medicine, at $389 per month, a discount of $598 off of the list price.
Novo Nordisk will provide widely-used insulin products, including NovoLog and Tresiba, at $35 per month of supply.
The agreement also provides that Eli Lilly and Novo Nordisk will guarantee MFN prices on all new medicines that they bring to market, repatriate increased foreign revenue on existing products, and provide every State Medicaid program in the country access to MFN drug prices on their products.
INVESTING IN AMERICA TO SECURE PHARMACEUTICAL SUPPLY CHAINS:
MAKING AMERICA HEALTHY AGAIN:
ENDING GLOBAL FREELOADING ON AMERICAN PHARMACEUTICAL INNOVATION:
DELIVERING ON PROMISES TO PUT AMERICAN PATIENTS FIRST:
Substack Note
Anonymous Media Group
Nov 07, 2025
Mark my words; what Trump just did by lowering cost of weight loss drugs like Ozempic is going to be devastating for so many people who normally wouldn’t be able to afford them.
This is not for the benefit of the people! These drugs are unbelievably dangerous and we haven’t seen just how bad they are yet. Just wait! The fallout is going to be devastating. https://substack.com/@anonymousmediagroup/note/c-174625182
Ozempic common side-effects and severe side-effects
Earlier in 2025, a relative was prescribed Ozempic. I mentioned this to a diabetic friend who had been prescribed Ozempic. The diabetic experienced such severe side-effects they did a deep dive into semaglutide. I obtained their research and posted what follows at the above Substack.
The following either contain the same active ingredient semaglutide as Ozempic, work similarly to Ozempic, or contain similar warnings and contraindications to Ozempic: Mounjar, Rybelsis, Saxenda, Trulicity, Victoza, Wegovy, Zepbound. You can look each up on your on to validate https://www.drugs.com/sfx/ozempic-side-effects.html
What do you think?
Without prejudice and without recourse
Doreen Agostino
Our Greater Destiny Blog
healthresources